Guest blog post by RSM 

What are the key business risks in healthcare and life sciences?

The need for healthcare and life sciences organisations to enhance their risk management arrangements is more essential than ever. Combined pressures in a post-pandemic environment, including increased cyber-attacks, the legislative and operational complexities following Brexit and changing regulatory frameworks, have seen the role of risk management change in recent years. Risks within the healthcare and life sciences industries are wide ranging and evolving. In this article, we explore the emergence of key risk themes.  Read More.

Global mobility and talent retention in UK life sciences

Since Brexit and Covid-19 shook up working practices, there has been a marked shift in the global approach to work location and increased demand from employees for flexibility. Life sciences is arguably one of the most impacted industries and therefore has key global workforce risks and challenges to consider. Read More. 

Spring budget changes to R&D – impact for UK life sciences

Innovation Reliefs Specialists, James Tetley and Lizzie Gosling, explore what has changed regarding R&D tax incentives and the impact for the UK’s life sciences and biotech industry. Read More.

*If you would like to submit a guest blog post, please email info@onenucleus.com*